TipRanks
Advertisement
Advertisement

DE:MVR0 Stock Latest News

Medivir Updates Share Structure Following LTIP 2023 Conversion
Company AnnouncementsMedivir Updates Share Structure Following LTIP 2023 Conversion
6d ago
Medivir Bolsters Finances as Fostrox and MIV-711 Advance in Key Phase II Programs
PremiumCompany Announcements
Medivir Bolsters Finances as Fostrox and MIV-711 Advance in Key Phase II Programs
2M ago
Medivir Expands Share Capital to Fund MIV-711 Orphan Indication
PremiumCompany Announcements
Medivir Expands Share Capital to Fund MIV-711 Orphan Indication
2M ago
Medivir Shareholders Approve Directed Issue to Bolster Drug Development
PremiumCompany Announcements
Medivir Shareholders Approve Directed Issue to Bolster Drug Development
3M ago
Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination
PremiumCompany Announcements
Medivir secures long-term U.S. patent protection for fostrox–lenvatinib liver cancer combination
3M ago
PremiumCompany AnnouncementsMedivir Expands Share Capital Following First Tranche of Directed Issue
3M ago
Premium
Company Announcements
Medivir Files Disclosure Document for Directed Share Issue on Nasdaq Stockholm
4M ago
Premium
Company Announcements
Medivir Calls Extraordinary General Meeting with Expanded Voting Options
4M ago
PremiumCompany Announcements
Medivir Raises SEK 140 Million to Accelerate MIV‑711 Development in Rare Pediatric Disease
4M ago
PremiumCompany Announcements
Medivir Plans SEK 130 Million Directed Share Issue to Advance Rare Pediatric Disease Drug
4M ago
PremiumCompany Announcements
Medivir’s fostrox combo shows promising liver cancer data in key journal
4M ago
PremiumCompany Announcements
Medivir Begins Key Phase 2 Trial of Fostrox Combo in Advanced Liver Cancer
5M ago
PremiumCompany AnnouncementsMedivir AGM Backs Board, Extends Capital Mandate and Adopts New Incentive Plan
5M ago
Premium
Company Announcements
Medivir Strengthens Finances and Pipeline as Key Cancer and Bone Programs Advance
5M ago
Premium
Company Announcements
Medivir targets Asian partnerships as it showcases liver cancer and bone disease drugs
6M ago
PremiumCompany Announcements
Medivir Delays Q1 Report as South Korea Liver Cancer Trial Expands
6M ago
PremiumCompany Announcements
Medivir Calls 2026 AGM, Details Shareholder Voting Procedures and Capital Structure
6M ago
Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
PremiumCompany Announcements
Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
6M ago
Medivir forms elite expert council to drive MIV-711 push in brittle bone disease
PremiumCompany Announcements
Medivir forms elite expert council to drive MIV-711 push in brittle bone disease
7M ago
Medivir to Showcase Phase 2 Advances for Key Cancer and Bone Disease Programs
PremiumCompany AnnouncementsMedivir to Showcase Phase 2 Advances for Key Cancer and Bone Disease Programs
7M ago
Medivir Names New CFO to Steer Next Phase of Strategic Transformation
Premium
Company Announcements
Medivir Names New CFO to Steer Next Phase of Strategic Transformation
7M ago
Medivir Expands Share Capital After Directed Issue to Carl Bennet AB
Premium
Company Announcements
Medivir Expands Share Capital After Directed Issue to Carl Bennet AB
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >